A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: Study design and rationale

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Ajay, Vamadevan S ^a,g   Tian, Maoyi ^b   Chen, Hao ^c   Wu, Yangfeng ^b   Li, Xian ^b   Dunzhu, Danzeng ^d   Ali, Mohammed K ^e   Tandon, Nikhil ^f   Krishnan, Anand ^f   Prabhakaran, Dorairaj ^a,g   Yan, Lijing L ^b,h  

^a PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c BEIJING HOSPITAL   (China)

^d TIBET UNIVERSITY   (China)

^e EMORY UNIVERSITY   (United States)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^g Centre for Chronic Disease Control   (India)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular diseases prevention and control; Community health workers; Developing countries; Electronic decision support system; Research design; Risk reduction; Rural population

Indexed keywords

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHINA; COMMUNITY CARE; CONTROLLED STUDY; HEALTH AUXILIARY; HUMAN; INDIA; MALE; MEDICATION THERAPY MANAGEMENT; METHODOLOGY; ORGANIZATION AND MANAGEMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHINA; COMMUNITY HEALTH SERVICES; COMMUNITY HEALTH WORKERS; HUMANS; INDIA; MALE; MEDICATION THERAPY MANAGEMENT; QUESTIONNAIRES; RESEARCH DESIGN; TIBET;

EID: 84907910551     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-924     Document Type: Article

References (50)

1. World Health Organization PHAoC, Preventing chronic diseases: a vital investment Geneva; Ottawa: World Health Organization; Public Health Agency of Canada 2005
2. Global inequalities in access to cardiovascular health care: our greatest challenge. Joshi R, Jan S, Wu Y, MacMahon S, J Am Coll Cardiol 2008 52 23 1817 1825 10.1016/j.jacc.2008.08.049 19038678
3. Cardiovascular disease in non-Western countries. Reddy KS, N Engl J Med 2004 350 24 2438 2440 10.1056/NEJMp048024 15190135
4. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Yusuf S, Reddy S, Ounpuu S, Anand S, Circulation 2001 104 22 2746 2753 10.1161/hc4601.099487 11723030
5. Cardiovascular diseases in China. Liu L, Biochem Cell Biol 2007 85 2 157 163 10.1139/O07-004 17534394
6. Mackay J, Mensah GA, Mendis S, Greenlund K, The Atlas of Heart Disease and Stroke World Health Organization: Geneva 2004
7. Hypertension prevalence, awareness, treatment and control rates in agricultural and pastoral areas in Tibet, China. Gusanglamu P, Cai YX, Rendan L, Zhong Guo Yi Xue Zhi Nan 2010 8 027 79 81
8. Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. Zhao X, Li S, Ba S, He F, Li N, Ke L, Li X, Lam C, Yan LL, Zhou Y, Wu Y, Am J Hypertens 2012 25 5 583 589 10.1038/ajh.2012.9 22357415
9. Risk factors for non-communicable disease in urban Haryana: a study using the STEPS approach. Anand K, Shah B, Gupta V, Khaparde K, Pau E, Menon GR, Kapoor SK, Indian Heart J 2008 60 1 9 18 19212016
10. Are the urban poor vulnerable to non-communicable diseases? A survey of risk factors for non-communicable diseases in urban slums of Faridabad. Anand K, Shah B, Yadav K, Singh R, Mathur P, Paul E, Kapoor SK, Natl Med J India 2007 20 3 115 120 17867614
11. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X, Circulation 2008 118 25 2679 2686 10.1161/CIRCULATIONAHA.108.788166 19106390
12. The Intercollegiate Working Party for Stroke, National Clinical Guidelines for Stroke. Update London: Royal College of Physicians 2002
13. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA, American Heart Association Stroke Council CoC, Stroke Nursing CoCC, Council on Peripheral Vascular D, Stroke 2014 45 7 2160 2236 10.1161/STR.0000000000000024 24788967
14. China guideline of hypertension updated 2005 Progression in the diagnosis and management of hypertension, China Hypertension League 2005
15. Non-pharmacological management of hypertension: optimal strategies for reducing cardiovascular risk. Beilin LJ, J Hypertens Suppl 1994 12 10 71 S81 7769495
16. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Clark AM, Hartling L, Vandermeer B, McAlister FA, Ann Intern Med 2005 143 9 659 672 10.7326/0003-4819-143-9-200511010-00010 16263889
17. Randomized trials of sodium reduction: an overview. Cutler JA, Follmann D, Allender PS, Am J Clin Nutr 1997 65 2 Suppl 643S 651S 9022560
18. An overview of randomized trials of sodium reduction and blood pressure. Cutler JA, Follmann D, Elliott P, Suh I, Hypertension 1991 17 1 Suppl 27 I33 1987008
19. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. European Society of Hypertension-European Society of Cardiology Guidelines C, J Hypertens 2003 21 6 1011 1053 12777938
20. Organization WH, Global strategy on diet, physical activity and health, F.-S.W.H. Assembly, Editor [ http://www.who.int/dietphysicalactivity/strategy/eb11344/strategyenglishweb.pdf ]
21. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Potter JF, Sever PS, Mc GTS, British Hypertension S, J Hum Hypertens 2004 18 3 139 185 10.1038/sj.jhh.1001683 14973512
22. National Vascular Disease Prevention Alliance, Guidelines for the Assessment of Absolute Cardiovascualr Disease Risk Melbourne: National Heart Foundation of Australia 2009
23. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C, JAMA 2003 289 19 2560 2572 doi:10.1001/jama.289.19.2560. PubMed PMID: 12748199 10.1001/jama.289.19.2560 12748199
24. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Gaziano TA, Opie LH, Weinstein MC, Lancet 2006 368 9536 679 686 10.1016/S0140-6736(06)69252-0 16920473
25. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH, Circulation 2005 112 23 3569 3576 10.1161/CIRCULATIONAHA.105.535922 16330698
26. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB, Lancet 2003 361 9359 717 725 10.1016/S0140-6736(03)12655-4 12620735
27. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Reddy KS, Public Health Nutr 2002 5 1A 231 237 12027289
28. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, Liu K, Cardiovascular U-PCSo, Cardiopulmonary Epidemiology Research G, China Multicenter Collaborative Study of Cardiovascular Epidemiology Research G, Circulation 2006 114 21 2217 2225 10.1161/CIRCULATIONAHA.105.607499 17088464
29. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh. Chow CK, Joshi R, Gottumukkala AK, Raju K, Raju R, Reddy S, Macmahon S, Neal B, India Am Heart J 2009 158 3 349 355 10.1016/j.ahj.2009.05.034
30. The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. Joshi R, Chow CK, Raju PK, Raju KR, Gottumukkala AK, Reddy KS, Macmahon S, Heritier S, Li Q, Dandona R, Neal B, J Am Coll Cardiol 2012 59 13 1188 1196 10.1016/j.jacc.2011.10.901 22440219
31. Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. Yan LL, Fang W, Delong E, Neal B, Peterson ED, Huang Y, Sun N, Yao C, Li X, MacMahon S, Wu Y, BMC Public Health 2014 14 345 10.1186/1471-2458-14-345 24721435
32. Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, West M, Barlow A, Lewis-Boyer L, Donnelly-Strozzo M, Curtis C, Anderson K, Circ Cardiovasc Qual Outcomes 2011 4 6 595 602 10.1161/CIRCOUTCOMES.111.961573 21953407
33. Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M, Varghese M, Thara R, Weiss HA, Williams P, McCrone P, Patel V, Thornicroft G, Lancet 2014 383 9926 1385 1394 10.1016/S0140-6736(13)62629-X 24612754
34. Dye CJ, Williams JE, Evatt JH, Improving Hypertension Self-Management With Community Health Coaches Health promotion practice. 2014
35. A community health worker intervention to improve management of hypertension among Filipino Americans in New York and New Jersey: a pilot study. Ursua RA, Aguilar DE, Wyatt LC, Katigbak C, Islam NS, Tandon SD, Nur PR, Van Devanter N, Rey MJ, Trinh-Shevrin C, Ethn Dis 2014 24 1 67 76 24620451
36. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A, Badruddin SH, Chaturvedi N, Hypertension Research G, Ann Intern Med 2009 151 9 593 601 10.7326/0003-4819-151-9-200911030-00004 19884620
37. Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers. Surka S, Edirippulige S, Steyn K, Gaziano T, Puoane T, Levitt N, Int J Med Inform 2014 83 9 648 654 10.1016/j.ijmedinf.2014.06.008 25002305
38. The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Beratarrechea A, Lee AG, Willner JM, Jahangir E, Ciapponi A, Rubinstein A, Telemed J E-health: Offic J Am Telemed Assoc 2014 20 1 75 82
39. CONSORT statement on the reporting standards in clinical trials. Recommendations are inappropriate for trial reports. Meade TW, Wald N, Collins R, BMJ 1997 314 7087 1126 10.1136/bmj.314.7087.1126
40. Chinese national hypertension prevention guideline 2010. Liu L, Lisheng Liu 2011 19 8 701 708
41. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E, Can J Cardiol 2013 29 2 151 167 10.1016/j.cjca.2012.11.032 23351925
42. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, et al. Circulation 2014 129 25 Suppl 2 49 S73 24222018
43. Interventions for cardiovascular disease prevention. Gupta R, Deedwania P, Cardiol Clin 2011 29 1 15 34 10.1016/j.ccl.2010.10.005 21257098
44. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation, Int J Behav Med 2012 19 4 403 488 10.1007/s12529-012-9242-5 23093473
45. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. Shroufi A, Chowdhury R, Anchala R, Stevens S, Blanco P, Han T, Niessen L, Franco OH, BMC Public Health 2013 13 285 10.1186/1471-2458-13-285 23537334
46. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). Tang L, Patao C, Chuang J, Wong ND, Am J Cardiol 2013 112 8 1126 1132 10.1016/j.amjcard.2013.05.064 23827404
47. Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Parker DR, Evangelou E, Eaton CB, Contemp Clin Trials 2005 26 2 260 267 10.1016/j.cct.2005.01.002 15837446
48. Reuters. 2013 http://www.reuters.com/article/2013/12/20/china-mobilesubscribers-idUSL4N0J51ZN20131220
49. Styles K, http://mobilemarketingmagazine.com/382m-smartphone-users-china/
50. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. Kawamoto K, Houlihan CA, Balas EA, Lobach DF, BMJ 2005 330 7494 765 10.1136/bmj.38398.500764.8F 15767266